Propofol Associated with a Shorter Duration of Mechanical Ventilation than Scheduled Intermittent Lorazepam: A Database Analysis Using Project Impact

Background: While one prospective controlled study in medical intensive care unit (ICU) patients demonstrated that sedation with propofol leads to a shorter duration of mechanical ventilation compared with scheduled intermittent intravenous lorazepam, its conclusions may not be applicable to surgical ICU patients and institutions not using daily sedation interruption. Objective: To compare the duration of mechanical ventilation between medical and surgical ICU patients receiving propofol versus scheduled intermittent lorazepam in routine clinical practice. Methods: Retrospective data (January 2001–December 2005) were obtained from the Project IMPACT database for medical and surgical ICU patients at Tufts-New England Medical Center, a 450 bed academic hospital. These patients had been mechanically ventilated for 24 hours or more and had received 24 hours or more of either propofol or scheduled intermittent lorazepam as the sole sedative. Clinically relevant variables were identified a priori, and their influence on duration of mechanical ventilation was evaluated. Differences in these variables between propofol and scheduled intermittent lorazepam groups within the ICU cohorts were then measured. Results: Of 4608 database patients, 287 met criteria. Factors associated with a prolonged duration of mechanical ventilation for the medical ICU cohort included sedation use for 5 or more days (OR 13.8; 95% CI 8.3 to 19.4), narcotic use (OR 7.6; 95% CI 2.3 to 13), and scheduled intermittent lorazepam use (OR 7.0; 95% CI 0.4 to 13.7). For the surgical ICU cohort, these factors included sedation use for 5 or more days (OR 15; 95% CI 11.4 to 19.4), APACHE II (Acute Physiology and Chronic Health Evaluation II) score equal to or greater than 18 (OR 4.1; 95% CI 0.4 to 7.8), and scheduled intermittent lorazepam use (OR 4.0; 95% CI 0.2 to 7.7). Duration of mechanical ventilation was the only variable that differed significantly between propofol and scheduled intermittent lorazepam in both the medical ICU, with a median (range) of 6 (3–12) versus 11 (5–25; p = 0.03), and surgical ICU, with a median of 4 (2–15) versus 9 (4–20; p = 0.001), groups. Conclusions: Sedation with propofol in the naturalistic setting appears to be associated with a shorter duration of mechanical ventilation compared with scheduled intermittent lorazepam in both medial and surgical ICU patients when only one sedative drug is used. Data from this uncontrolled observational study are consistent with findings from a randomized clinical trial.

[1]  P. Halpern,et al.  Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison , 1997, Intensive Care Medicine.

[2]  B. Gersh External Validity of Clinical Trials in Acute Myocardial Infarction , 2008 .

[3]  G. Fraser,et al.  Comfort without coma: changing sedation practices. , 2007, Critical care medicine.

[4]  F. Van de Werf,et al.  External validity of clinical trials in acute myocardial infarction. , 2007, Archives of internal medicine.

[5]  J. Devlin,et al.  Identifying factors that could account for differences in duration of mechanical ventilation between intermittent lorazepam- and propofol-treated patients. , 2006, Critical care medicine.

[6]  Jesse B. Hall,et al.  Sedation in the mechanically ventilated patient , 2006, Critical care medicine.

[7]  Lorazepam concentrations, pharmacokinetics and pharmacodynamics in a cohort of mechanically ventilated ICU patients. , 2006, International journal of clinical pharmacology and therapeutics.

[8]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[9]  Jesse B. Hall,et al.  A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients* , 2006, Critical care medicine.

[10]  S. Nasraway,et al.  Morbid obesity is an independent determinant of death among surgical critically ill patients* , 2006, Critical care medicine.

[11]  J. Devlin,et al.  Intensive care unit sedation: waking up clinicians to the gap between research and practice. , 2006, Critical care medicine.

[12]  R. Bies,et al.  Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety 1 , 2005, Journal of clinical pharmacy and therapeutics.

[13]  J. Peterson,et al.  Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients , 2005, Critical care.

[14]  S. Kane-Gill,et al.  Comparing Dexmedetomidine Prescribing Patterns and Safety in the Naturalistic Setting Versus Published Data , 2004, The Annals of pharmacotherapy.

[15]  S. Cook,et al.  Project IMPACT: Results from a Pilot Validity Study of a New Observational Database , 2002, Critical care medicine.

[16]  Carlayne E. Jackson,et al.  Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[17]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[18]  A. Connors Pitfalls in estimating the effect of interventions in the critically ill using observational study designs. , 2001, Critical care medicine.

[19]  D. Cook,et al.  On the need for observational studies to design and interpret randomized trials in ICU patients: a case study in stress ulcer prophylaxis , 2001, Intensive Care Medicine.

[20]  M. Shapiro,et al.  Daily interruption of sedative infusions in critically ill patients. , 2000, New England Journal of Medicine.

[21]  J. Mazuski,et al.  Daily interruption of sedative infusions in critically ill patients. , 2000, The New England journal of medicine.

[22]  J. Kress,et al.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. , 2000, The New England journal of medicine.

[23]  S. Lemeshow,et al.  Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterization. , 2000, JAMA.

[24]  J. Kress,et al.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. , 2000, The New England journal of medicine.

[25]  G Sherman,et al.  Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. , 1999, Critical care medicine.

[26]  G. Fraser,et al.  Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. , 1999, Critical care medicine.

[27]  G Sherman,et al.  The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. , 1998, Chest.

[28]  E. Alted-López,et al.  Propofol Versus Midazolam: Safety and Efficacy for Sedating the Severe Trauma Patient , 1998, Anesthesia and analgesia.

[29]  J. Devlin,et al.  The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost , 1997, The Annals of pharmacotherapy.

[30]  R. Barrientos-Vega,et al.  Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. , 1997, Critical care medicine.

[31]  M. Barrios,et al.  Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. , 1996, Critical care medicine.

[32]  J. Concato,et al.  The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.

[33]  G. Carrasco,et al.  Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. , 1993, Chest.

[34]  G. Bailie,et al.  Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. , 1992, British journal of anaesthesia.

[35]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .